Inventor · disambiguated record
Jeffrey T. L. Smith
Also filed as: SMITH JEFFREY · SMITH JEFFREY T · SMITH JEFFREY T L
117 granted patents·37 pending applications·1,324 citations·filing 2003–2025
99Inventor score
Files withALDERBIO HOLDINGS LLC70H LUNDBECK AS28SMITH JEFFREY T L13ALDER BIOPHARMACEUTICALS INC9GARCIA-MARTINEZ LEON7
Top patents by PatentIndex Score
154 records- 0198US8992920B2Anti-IL-6 antibodies for the treatment of arthritisSMITH JEFFREY T L·Filed 2011·Granted Mar 31, 2015·29 cites·61 claims
- 0298US8337847B2Methods of treating anemia using anti-IL-6 antibodiesSMITH JEFFREY T L·Filed 2009·Granted Dec 25, 2012·48 cites·35 claims
- 0398US8277804B2Antagonists of IL-6 to prevent or treat thrombosisSMITH JEFFREY T L·Filed 2009·Granted Oct 2, 2012·54 cites·46 claims
- 0498US7935340B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2008·Granted May 3, 2011·111 cites·28 claims
- 0598US7906117B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2008·Granted Mar 15, 2011·55 cites·23 claims
- 0697US11938185B2Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 26, 2024·3 cites·42 claims
- 0797US9765138B2Isolated anti-IL-6 antibodiesALDERBIO HOLDINGS LLC·Filed 2015·Granted Sep 19, 2017·10 cites·28 claims
- 0897US8404235B2Antagonists of IL-6 to raise albumin and/or lower CRPSMITH JEFFREY T L·Filed 2008·Granted Mar 26, 2013·30 cites·29 claims
- 0997US8323649B2Antibodies to IL-6 and use thereofGARCIA-MARTINEZ LEON·Filed 2009·Granted Dec 4, 2012·56 cites·28 claims
- 1097US8252286B2Antagonists of IL-6 to prevent or treat thrombosisSMITH JEFFREY T L·Filed 2008·Granted Aug 28, 2012·45 cites·25 claims
- 1197US8178101B2Use of anti-IL-6 antibodies having specific binding properties to treat cachexiaGARCIA-MARTINEZ LEON·Filed 2009·Granted May 15, 2012·48 cites·16 claims
- 1297US8062864B2Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodiesGARCIA-MARTINEZ LEON·Filed 2009·Granted Nov 22, 2011·52 cites·55 claims
- 1397US6953787B25HT2C receptor modulatorsARENA PHARM INC·Filed 2003·Granted Oct 11, 2005·79 cites·77 claims
- 1496US11639380B2Acute treatment and rapid treatment of headache using anti-CGRP antibodiesH LUNDBECK AS·Filed 2020·Granted May 2, 2023·11 cites·11 claims
- 1596US9957321B2Anti-IL-6 antibodies for the treatment of oral mucositisALDERBIO HOLDINGS LLC·Filed 2015·Granted May 1, 2018·15 cites·18 claims
- 1696US9926370B2Antagonists of IL-6 to prevent or treat thrombosisALDERBIO HOLDINGS LLC·Filed 2015·Granted Mar 27, 2018·10 cites·21 claims
- 1796US9884912B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2014·Granted Feb 6, 2018·15 cites·13 claims
- 1896US9717793B2Method of improving patient survivability and quality of life by administering an anti-IL-6 antibodyALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 1, 2017·15 cites·24 claims
- 1996US9085615B2Antibodies to IL-6 to inhibit or treat inflammationALDERBIO HOLDINGS LLC·Filed 2012·Granted Jul 21, 2015·29 cites·32 claims
- 2096US8535671B2Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificitySMITH JEFFREY T L·Filed 2011·Granted Sep 17, 2013·25 cites·28 claims
- 2196US8420089B2Antagonists of IL-6 to raise albumin and/or lower CRPSMITH JEFFREY T L·Filed 2009·Granted Apr 16, 2013·32 cites·36 claims
- 2296US7977329B25HT2C receptor modulatorsARENA PHARM INC·Filed 2006·Granted Jul 12, 2011·33 cites·18 claims
- 2395US12162936B2Methods of treatment with anti-PACAP antibodiesH LUNDBECK AS·Filed 2021·Granted Dec 10, 2024·2 cites·23 claims
- 2495US11993648B2Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversionH LUNDBECK AS·Filed 2020·Granted May 28, 2024·3 cites·9 claims
- 2595US11639381B2Treatment of headache using anti-CGRP antibodiesH LUNDBECK·Filed 2020·Granted May 2, 2023·12 cites·15 claims
- 2695US10975135B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 13, 2021·4 cites·34 claims
- 2795US10968268B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 6, 2021·4 cites·34 claims
- 2895US10954285B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 23, 2021·4 cites·34 claims
- 2995US10266587B2Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferersALDERBIO HOLDINGS LLC·Filed 2017·Granted Apr 23, 2019·12 cites·4 claims
- 3095US9994635B2Antagonists of IL-6 to raise albumin and/or lower CRPALDERBIO HOLDINGS LLC·Filed 2016·Granted Jun 12, 2018·13 cites·14 claims
- 3195US9701747B2Method of improving patient survivability and quality of life by anti-IL-6 antibody administrationALDERBIO HOLDINGS LLC·Filed 2013·Granted Jul 11, 2017·17 cites·15 claims
- 3295US9452227B2Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragmentsGARCIA-MARTINEZ LEON·Filed 2009·Granted Sep 27, 2016·27 cites·21 claims
- 3394US9834603B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Dec 5, 2017·7 cites·11 claims
- 3494US8911734B2Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75LATHAM JOHN A·Filed 2011·Granted Dec 16, 2014·40 cites·45 claims
- 3594US8728473B2Methods of preventing or treating pain using anti-NGF antibodiesGARCIA-MARTINEZ LEON F·Filed 2011·Granted May 20, 2014·27 cites·52 claims
- 3693US10053506B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 21, 2018·9 cites·14 claims
- 3793US9821057B2Anti-IL-6 antibody for use in the treatment of cachexiaALDERBIO HOLDINGS LLC·Filed 2015·Granted Nov 21, 2017·9 cites·1 claims
- 3893US9724410B2Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicitySMITH JEFFREY T L·Filed 2010·Granted Aug 8, 2017·13 cites·25 claims
- 3993US9725509B2Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibodyALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 8, 2017·9 cites·34 claims
- 4093US9187560B2Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2012·Granted Nov 17, 2015·8 cites·19 claims
- 4193US8992908B2Anti-IL-6 antibodies for the treatment of oral mucositisSMITH JEFFREY T L·Filed 2011·Granted Mar 31, 2015·14 cites·35 claims
- 4293US7514422B25HT2c receptor modulatorsARENA PHARM INC·Filed 2004·Granted Apr 7, 2009·36 cites·54 claims
- 4392US10787511B2Antagonists of IL-6 to raise albumin and/or lower CRPALDERBIO HOLDINGS LLC·Filed 2018·Granted Sep 29, 2020·3 cites·10 claims
- 4492US10640560B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or feverALDERBIO HOLDINGS LLC·Filed 2018·Granted May 5, 2020·3 cites·12 claims
- 4592US10227404B2Antagonists of IL-6 to raise albumin and/or lower CRPALDERBIO HOLDINGS LLC·Filed 2017·Granted Mar 12, 2019·4 cites·17 claims
- 4692US10202435B2Anti-PACAP antibodies and uses thereofALDER BIOPHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·9 cites·19 claims
- 4792US9468676B2Antagonists of IL-6 to prevent or treat thrombosisSMITH JEFFREY T L·Filed 2010·Granted Oct 18, 2016·12 cites·31 claims
- 4892US8273734B15HT2C receptor modulatorsSMITH BRIAN·Filed 2012·Granted Sep 25, 2012·12 cites·45 claims
- 4992US8207158B25HT2c receptor modulatorsSMITH BRIAN·Filed 2011·Granted Jun 26, 2012·12 cites·120 claims
- 5091US11427631B2Anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2020·Granted Aug 30, 2022·2 cites·26 claims
Showing the top 50 of 154 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeffrey T. L. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →